Clinical Trials

MSK

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 5 of 5 Clinical Trials Related to MSK

MSK 18-400

A Phase II Trial of the PD-1 Antibody Nivolumab in Combination with Hypofractionated Re-Irradiation and Bevacizumab for Recurrent MGMT Methylated Glioblastoma

Doctor(s) Running This Study

MSK17-261

A Phase 2 Study of Abemaciclib in Patients with Recurrent Primary Brain Tumors

Doctor(s) Running This Study

MSK 18-486

A Phase II Randomized Study Assessing the Efficacy of Stereotactic Body Radiotherapy (SBRT) in Patients with Oligometastatic Solid Tumors

Doctor(s) Running This Study

MSK 17-180

Phase II Trial of Single-Agent Nivolumab in Patients with Microsatellite Unstable/Mismatch Repair Deficient/Hypermutated Uterine Cancer

Doctor(s) Running This Study